Early age of onset in fatal familial insomnia |
| |
Authors: | Dr. A. Harder A. Gregor T. Wirth F. Kreuz W. J. Schulz-Schaeffer O. Windl M. Plotkin H. Amthauer K. Neukirch H. A.. Kretzschmar T. Kuhlmann R. Braas H. H. Hahne K. Jendroska |
| |
Affiliation: | (1) Institute of Neuropathology, Charité Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany;(2) German Military Hospital, Berlin, Germany;(3) Clinics of Erlabrunn GmbH, Erlabrunn, Germany;(4) Institute of Clinical Genetics, Medical Faculty, Carl Gustav Carus Technical University Dresden, Dresden, Germany;(5) Institute of Neuropathology, University Göttingen, Göttingen, Germany;(6) Institute of Neuropathology, Ludwig Maximilians University Munich, CJD Surveillance, Munich, Germany;(7) Dept. of Radiology, Charité Humboldt University, Berlin, Germany;(8) Dept. of Neurology, Charité Humboldt University, Berlin, Germany |
| |
Abstract: | Abstract. Fatal familial insomnia (FFI) is a prion disease exhibiting the PRNP D178N/129M genotype. Features of this autosomal dominant illness are progressive insomnia, dysautonomia, myoclonus, cognitive decline and motor signs associated with thalamic nerve cell loss and gliosis. In contrast to the new variant of Creutzfeldt-Jakob disease (vCJD) the onset of FFI is in middle to late adulthood. We report two male patients who belong to a large German FFI kindred. They were examined clinically, and postmortem neuropathological examination was carried out in collaboration with the German reference centre for prion disease. Additionally, the prion protein gene (PRNP) was analysed. To identify further patients with disease onset under 30 years of age a comprehensive literature review was carried out. Two male patients presented with typical symptoms of FFI at the age of 23 and 24 years. In their kindred, the age of onset has never before been under 44 years of age. Our literature review identified five additional early onset cases who died at age 21 to 25 years. In all 22 reviewed FFI families the median manifestation age was 49.5 years. Although phenotypic variability of FFI is common, age of onset under 30 years has been considered to be a hallmark of vCJD with a mean manifestation at 27 years of age. Our findings underline that in addition to vCJD, FFI must be considered in cases of young-onset prion disease. This has considerable impact on clinical management and genetic counselling.* These two authors contributed equally |
| |
Keywords: | fatal familial insomnia FFI literature review human prion disease |
本文献已被 PubMed SpringerLink 等数据库收录! |
|